Raju Mohan, Chief Executive Officer at Ventyx Biosciences, Inc. (VTYX), sold 600,000 shares at $29.15 ($17.4M) on 2022-12-05, disclosed to the SEC on 2022-12-06.
Open-market sale of $17.4M VTYX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.01 | 276,997 | $8.0M | 46.2% |
| 2 | $29.01 | 276,997 | $8.0M | 46.2% |
| 3 | $28.33 | 19,896 | $564K | 3.2% |
| 4 | $28.33 | 19,896 | $564K | 3.2% |
| 5 | $29.15 | 3,107 | $91K | 0.5% |
| 6 | $29.15 | 3,107 |
| $91K |
| 0.5% |
| Total | $28.97 avg | 600,000 | $17.4M | 100% |
| Filing → |
| VTYX | SELL | 2024-04-03 | $23K | — | Filing → |
| VTYX | SELL | 2023-12-21 | $250K | — | Filing → |
| VTYX | SELL | 2023-10-06 | $873K | — | Filing → |